An researcher from Zahedan University of Medical Sciences Received Gold Medal Certificate at International Invention and Innovation Competition for IFIA INV Members, Switzerland, August 2022
Dr. Rouhi Afkari, Director of Department of Research and Development at Vice-chancellery for Food and Drug, Zahedan University of Medical Sciences, was awarded a gold certificate at the Second International Competition for Inventors and Innovators organized by International Federation of Inventors Association (IFIA), Switzerland.
G5 High Level Expert Meeting on Health Cooperation was held in Tehran, Islamic Republic of Iran, 6-7 Sep. 2022
The G5 meeting was held in Tehran, Iran in 6-7 September 2022, with the presence of delegations from Iran, Pakistan, Afghanistan, Iraq and the World Health Organization with the theme of “Joint Work for Solving Joint Health Problems”. The participants included senior level professionals of the four countries.
In Pictures: Zahedan University of Medical Sciences Launches the First Polio Vaccination Campaign in 2022
ZAUMS launches first polio vaccination campaign of 2022. Polio immunization drive will last for one week and aims to vaccinate over 400 thousand children under the age of five living in Sistan and Balouchestan Province. More than 2800 healthcare workers and community health volunteer teams to take part in the campaign adhering to strict COVID-19 precautionary measures.
In Pictures: Zahedan University of Medical Sciences Launches First Polio Vaccination Campaign in 2022
ZAUMS launches first polio vaccination campaign of 2022. Polio immunization drive will last for one week and aims to vaccinate over 400 thousand children under the age of five living in Sistan and Balouchestan Province. More than 2800 healthcare workers and community health volunteer teams to take part in the campaign adhering to strict COVID-19 precautionary measures.
Intensifying the implementation of recommended public health measures in schools amid the spread of omicron variant
On Nov. 26, the World Health Organization named the Omicron variant of the coronavirus a new variant of concern. The variant was first identified in South Africa and Botswana, and has been detected in at least 110 nations.
Intensified COVID-19 Surveillance under new alert level system at the Mirjaveh-Pakistan border crossing amid the spread of Omicron Variant
On November 26, 2021, the World Health Organization (WHO) classified a new variant, B.1.1.529, as a Variant of Concern, and has named it Omicron. The variant was first identified in South Africa and Botswana, and cases of this variant have been identified in more than 85 nations to date. It is spreading rapidly in several countries, including Britain, Denmark and Norway.
Intensified COVID-19 Disease Surveillance under new alert level system at the Mirjaveh-Pakistan border crossing amid the spread of Omicron Variant
On November 26, 2021, the World Health Organization (WHO) classified a new variant, B.1.1.529, as a Variant of Concern, and has named it Omicron. The variant was first identified in South Africa and Botswana, and cases of this variant have been identified in more than 85 nations to date. It is spreading rapidly in several countries, including Britain, Denmark and Norway.
Zahedan University of Medical Sciences is conducting a COVID-19 vaccination campaign to improve COVID-19 vaccine coverage among the target population
Vaccinations are the only way to end this pandemic. As of November 18, 2021, nearly 7.6 billion COVID-19 vaccine doses have been administered worldwide. Vaccination rates across countries and the return to a more normal life are still major topics around the globe. But with entering the second winter season of the pandemic, the tracking of coronavirus cases and deaths and the emergence of potentially perilous new variants of the virus will probably become more prominent again.
Zahedan University of Medical Sciences is conducting a COVID-19 vaccination campaign to improve COVID-19 vaccine coverage among the target population
Vaccinations are the only way to end this pandemic. As of November 18, 2021, nearly 7.6 billion COVID-19 vaccine doses have been administered worldwide. Vaccination rates across countries and the return to a more normal life are still major topics around the globe. But with entering the second winter season of the pandemic, the tracking of coronavirus cases and deaths and the emergence of potentially perilous new variants of the virus will probably become more prominent again.